share_log

The One-year Underlying Earnings Growth at Beijing Wandong Medical TechnologyLtd (SHSE:600055) Is Promising, but the Shareholders Are Still in the Red Over That Time

The One-year Underlying Earnings Growth at Beijing Wandong Medical TechnologyLtd (SHSE:600055) Is Promising, but the Shareholders Are Still in the Red Over That Time

北京萬東醫療科技股份有限公司(SHSE: 600055)一年的基礎收益增長令人鼓舞,但在此期間,股東仍處於虧損狀態
Simply Wall St ·  03/27 15:21

Passive investing in an index fund is a good way to ensure your own returns roughly match the overall market. But if you buy individual stocks, you can do both better or worse than that. That downside risk was realized by Beijing Wandong Medical Technology Co.,Ltd. (SHSE:600055) shareholders over the last year, as the share price declined 35%. That's well below the market decline of 13%. On the other hand, the stock is actually up 14% over three years.

被動投資指數基金是確保自己的回報與整個市場大致相匹配的好方法。但是,如果你買入個股,你的表現可能比這更好或更差。這種下行風險是由北京萬東醫療科技有限公司實現的。由於股價下跌了35%,有限公司(上海證券交易所股票代碼:600055)的股東。這遠低於13%的市場跌幅。另一方面,股票實際上是 向上 三年內達到 14%。

With the stock having lost 4.8% in the past week, it's worth taking a look at business performance and seeing if there's any red flags.

由於該股在過去一週下跌了4.8%,值得看一下業務表現,看看是否存在任何危險信號。

To quote Buffett, 'Ships will sail around the world but the Flat Earth Society will flourish. There will continue to be wide discrepancies between price and value in the marketplace...' By comparing earnings per share (EPS) and share price changes over time, we can get a feel for how investor attitudes to a company have morphed over time.

引用巴菲特的話說:“船隻將在世界各地航行,但Flat Earth Society將蓬勃發展。市場上的價格和價值之間將繼續存在巨大差異...”通過比較每股收益(EPS)和一段時間內的股價變化,我們可以了解投資者對公司的態度是如何隨着時間的推移而變化的。

During the unfortunate twelve months during which the Beijing Wandong Medical TechnologyLtd share price fell, it actually saw its earnings per share (EPS) improve by 1.1%. It's quite possible that growth expectations may have been unreasonable in the past.

在北京萬東醫療科技有限公司股價下跌的不幸十二個月中,其每股收益(EPS)實際上增長了1.1%。過去的增長預期很可能不合理。

By glancing at these numbers, we'd posit that the the market had expectations of much higher growth, last year. But other metrics might shed some light on why the share price is down.

通過看一眼這些數字,我們假設市場預計去年會有更高的增長。但是其他指標可能會爲股價下跌的原因提供一些啓示。

With a low yield of 0.9% we doubt that the dividend influences the share price much. Beijing Wandong Medical TechnologyLtd managed to grow revenue over the last year, which is usually a real positive. Since we can't easily explain the share price movement based on these metrics, it might be worth considering how market sentiment has changed towards the stock.

由於收益率爲0.9%,我們懷疑股息是否會對股價產生很大影響。去年,北京萬東醫療科技有限公司成功實現了收入增長,這通常是一個真正的積極因素。由於我們無法根據這些指標輕鬆解釋股價走勢,因此可能值得考慮市場對該股的情緒發生了怎樣的變化。

The graphic below depicts how earnings and revenue have changed over time (unveil the exact values by clicking on the image).

下圖描述了收入和收入隨時間推移而發生的變化(點擊圖片即可顯示確切的數值)。

earnings-and-revenue-growth
SHSE:600055 Earnings and Revenue Growth March 27th 2024
SHSE: 600055 收益和收入增長 2024 年 3 月 27 日

You can see how its balance sheet has strengthened (or weakened) over time in this free interactive graphic.

您可以在這張免費的交互式圖片中看到其資產負債表如何隨着時間的推移而增強(或減弱)。

A Different Perspective

不同的視角

We regret to report that Beijing Wandong Medical TechnologyLtd shareholders are down 34% for the year (even including dividends). Unfortunately, that's worse than the broader market decline of 13%. Having said that, it's inevitable that some stocks will be oversold in a falling market. The key is to keep your eyes on the fundamental developments. Longer term investors wouldn't be so upset, since they would have made 1.9%, each year, over five years. If the fundamental data continues to indicate long term sustainable growth, the current sell-off could be an opportunity worth considering. While it is well worth considering the different impacts that market conditions can have on the share price, there are other factors that are even more important. For example, we've discovered 2 warning signs for Beijing Wandong Medical TechnologyLtd that you should be aware of before investing here.

我們遺憾地報告,北京萬東醫療科技有限公司的股東今年下跌了34%(甚至包括股息)。不幸的是,這比整個市場13%的跌幅還要嚴重。話雖如此,在下跌的市場中,一些股票不可避免地會被超賣。關鍵是要密切關注基本發展。長期投資者不會那麼沮喪,因爲他們將在五年內每年賺1.9%。如果基本面數據繼續顯示長期可持續增長,那麼當前的拋售可能是一個值得考慮的機會。儘管市場狀況可能對股價產生的不同影響值得考慮,但還有其他因素更爲重要。例如,我們發現了北京萬東醫療科技有限公司的兩個警告信號,在投資這裏之前,你應該注意這些信號。

We will like Beijing Wandong Medical TechnologyLtd better if we see some big insider buys. While we wait, check out this free list of growing companies with considerable, recent, insider buying.

如果我們看到一些重大的內幕收購,我們會更喜歡北京萬東醫療技術有限公司。在我們等待的同時,請查看這份免費清單,列出了最近有大量內幕收購的成長型公司。

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Chinese exchanges.

請注意,本文引用的市場回報反映了目前在中國交易所交易的股票的市場加權平均回報。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論